image
Healthcare - Medical - Care Facilities - NYSE - US
$ 100.215
0.0749 %
$ 10.1 B
Market Cap
22.32
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one EHC stock under the worst case scenario is HIDDEN Compared to the current market price of 100 USD, Encompass Health Corporation is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one EHC stock under the base case scenario is HIDDEN Compared to the current market price of 100 USD, Encompass Health Corporation is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one EHC stock under the best case scenario is HIDDEN Compared to the current market price of 100 USD, Encompass Health Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
5.37 B REVENUE
11.91%
599 M OPERATING INCOME
-18.09%
597 M NET INCOME
64.99%
-3.1 M OPERATING CASH FLOW
-0.36%
-653 M INVESTING CASH FLOW
-8.38%
-331 M FINANCING CASH FLOW
-67.65%
1.4 B REVENUE
4.00%
164 M OPERATING INCOME
-21.66%
148 M NET INCOME
29.08%
268 M OPERATING CASH FLOW
23.18%
-195 M INVESTING CASH FLOW
-35.75%
-196 M FINANCING CASH FLOW
-203.72%
Balance Sheet Encompass Health Corporation
image
Current Assets 842 M
Cash & Short-Term Investments 69.1 M
Receivables 612 M
Other Current Assets 161 M
Non-Current Assets 5.26 B
Long-Term Investments 110 M
PP&E 3.51 B
Other Non-Current Assets 1.64 B
Current Liabilities 656 M
Accounts Payable 170 M
Short-Term Debt 48.9 M
Other Current Liabilities 438 M
Non-Current Liabilities 3.15 B
Long-Term Debt 2.86 B
Other Non-Current Liabilities 293 M
EFFICIENCY
Earnings Waterfall Encompass Health Corporation
image
Revenue 5.37 B
Cost Of Revenue 2.9 B
Gross Profit 2.47 B
Operating Expenses 1.61 B
Operating Income 599 M
Other Expenses 2.8 M
Net Income 597 M
RATIOS
46.01% GROSS MARGIN
46.01%
11.16% OPERATING MARGIN
11.16%
8.48% NET MARGIN
8.48%
0.00% ROE
0.00%
0.00% ROA
0.00%
0.00% ROIC
0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Encompass Health Corporation
image
Net Income 597 M
Depreciation & Amortization 300 M
Capital Expenditures -642 M
Stock-Based Compensation 48.3 M
Change in Working Capital 0
Others -958 M
Free Cash Flow -646 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Encompass Health Corporation
image
Wall Street analysts predict an average 1-year price target for EHC of $101 , with forecasts ranging from a low of $95 to a high of $110 .
EHC Lowest Price Target Wall Street Target
95 USD -5.20%
EHC Average Price Target Wall Street Target
101 USD 0.98%
EHC Highest Price Target Wall Street Target
110 USD 9.76%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.17 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Encompass Health Corporation
image
Sold
0-3 MONTHS
496 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.06 M USD 1
9-12 MONTHS
5.82 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
167 K USD 1
9-12 MONTHS
Date Value Insider Amount Avg Price
2 weeks ago
Feb 13, 2025
Sell 496 K USD
Price Andrew L
Chief Accounting Officer
- 5042
98.29 USD
6 months ago
Aug 13, 2024
Sell 1.05 M USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 12162
86.33 USD
6 months ago
Aug 13, 2024
Sell 8.53 K USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 98
87.03 USD
9 months ago
May 24, 2024
Sell 850 K USD
Charbonneau Elissa Joy
Chief Medical Officer
- 10000
85.02 USD
9 months ago
May 06, 2024
Sell 1.22 M USD
Darby John Patrick
EVP, Gen Counsel & Secretary
- 14543
83.94 USD
10 months ago
May 03, 2024
Bought 167 K USD
CARMICHAEL GREG D
Director
+ 2000
83.73 USD
10 months ago
Apr 30, 2024
Sell 3.75 M USD
Tarr Mark J
President & CEO
- 44976
83.27 USD
1 year ago
Nov 13, 2023
Sell 711 K USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 11215
63.39 USD
1 year ago
Aug 17, 2023
Sell 577 K USD
Charbonneau Elissa Joy
Chief Medical Officer
- 8294
69.58 USD
1 year ago
Aug 16, 2023
Sell 1.8 M USD
Tarr Mark J
President & CEO
- 25330
71.06 USD
2 years ago
Feb 10, 2023
Sell 1.09 M USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 17895
60.78 USD
2 years ago
Oct 31, 2022
Bought 100 K USD
CARMICHAEL GREG D
Director
+ 1830
54.67 USD
2 years ago
Aug 17, 2022
Sell 1.09 M USD
Tarr Mark J
President & CEO
- 20449
53.25 USD
2 years ago
May 05, 2022
Bought 66.5 K USD
O'Connor Kevin J.
director:
+ 1000
66.48 USD
3 years ago
Dec 02, 2021
Bought 20 K USD
Williams Terrance
Director
+ 354
56.61 USD
3 years ago
Mar 08, 2021
Sell 699 K USD
Price Andrew L
Chief Accounting Officer
- 8589
81.4 USD
4 years ago
Nov 17, 2020
Sell 500 K USD
Charbonneau Elissa Joy
Chief Medical Officer
- 6650
75.22 USD
4 years ago
May 28, 2020
Sell 1.74 M USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 23011
75.73 USD
4 years ago
May 28, 2020
Sell 37.3 K USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 490
76.15 USD
4 years ago
May 15, 2020
Sell 162 K USD
Jacobsmeyer Barbara Ann
President, Inpatient Hospitals
- 2500
64.73 USD
4 years ago
May 14, 2020
Sell 1.62 M USD
Tarr Mark J
President & CEO
- 26132
61.92 USD
4 years ago
Mar 12, 2020
Sell 118 K USD
CORRELL DONALD L
Director
- 2000
59.04 USD
4 years ago
Mar 12, 2020
Bought 491 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 8083
60.76 USD
4 years ago
Mar 12, 2020
Bought 1.23 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 20580
59.95 USD
4 years ago
Mar 12, 2020
Bought 2.45 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 41607
58.91 USD
4 years ago
Mar 12, 2020
Bought 2.26 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 38882
58.09 USD
4 years ago
Mar 12, 2020
Bought 615 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 10738
57.29 USD
4 years ago
Mar 12, 2020
Bought 249 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 4410
56.44 USD
4 years ago
Mar 12, 2020
Bought 38.2 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 700
54.5 USD
4 years ago
Mar 11, 2020
Bought 64.1 K USD
HIGDON LEO I JR
Director
+ 1000
64.07 USD
4 years ago
Mar 11, 2020
Bought 2.57 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 40000
64.24 USD
5 years ago
Nov 05, 2019
Bought 34.6 K USD
CURL YVONNE M
Director
+ 500
69.19 USD
5 years ago
May 01, 2019
Sell 2.77 M USD
Tarr Mark J
President & CEO
- 43439
63.74 USD
5 years ago
May 01, 2019
Sell 1.51 M USD
Tarr Mark J
President & CEO
- 23943
63.23 USD
5 years ago
Mar 07, 2019
Bought 58.8 K USD
HIGDON LEO I JR
Director
+ 1000
58.84 USD
6 years ago
Aug 14, 2018
Sell 757 K USD
Price Andrew L
Chief Accounting Officer
- 9457
80.04 USD
6 years ago
Aug 03, 2018
Sell 2.26 M USD
Levy Cheryl B.
Chief Human Resources Officer
- 28955
78 USD
6 years ago
May 14, 2018
Sell 113 K USD
Jacobsmeyer Barbara Ann
President, Inpatient Hospitals
- 1798
62.73 USD
6 years ago
May 09, 2018
Sell 1.95 M USD
Levy Cheryl B.
Chief Human Resources Officer
- 30982
63 USD
6 years ago
May 02, 2018
Sell 244 K USD
Jacobsmeyer Barbara Ann
President, Inpatient Hospitals
- 3897
62.51 USD
6 years ago
May 01, 2018
Sell 1 M USD
Tarr Mark J
President & CEO
- 16525
60.6 USD
6 years ago
May 01, 2018
Sell 1.02 M USD
Tarr Mark J
President & CEO
- 16575
61.32 USD
7 years ago
Nov 01, 2017
Bought 46 K USD
CURL YVONNE M
Director
+ 1000
45.95 USD
7 years ago
Aug 07, 2017
Sell 973 K USD
Tarr Mark J
President & CEO
- 22625
43 USD
7 years ago
Aug 03, 2017
Sell 963 K USD
Tarr Mark J
President & CEO
- 22625
42.55 USD
8 years ago
Nov 09, 2016
Bought 250 K USD
Tarr Mark J
EVP and COO
+ 6371
39.29 USD
8 years ago
Nov 09, 2016
Bought 252 K USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
+ 6450
39.14 USD
8 years ago
Aug 02, 2016
Sell 837 K USD
Tarr Mark J
EVP and COO
- 20000
41.8529 USD
8 years ago
Apr 29, 2016
Sell 456 K USD
Levy Cheryl B.
Chief Human Resources Officer
- 11000
41.44 USD
9 years ago
Feb 29, 2016
Sell 99.4 K USD
Fay Edmund
Sr. Vice Pres. and Treasurer
- 2800
35.5 USD
9 years ago
Mar 01, 2016
Sell 477 K USD
Fay Edmund
Sr. Vice Pres. and Treasurer
- 13440
35.5 USD
9 years ago
Jan 11, 2016
Bought 393 USD
CHIDSEY JOHN
Director
+ 11
35.769 USD
9 years ago
Jan 11, 2016
Bought 28.2 K USD
CHIDSEY JOHN
Director
+ 788
35.782 USD
9 years ago
Nov 16, 2015
Bought 9.9 K USD
Charbonneau Elissa Joy
Chief Medical Officer
+ 294
33.676 USD
9 years ago
Nov 05, 2015
Bought 35.3 K USD
HERMAN JOAN E
Director
+ 1000
35.278 USD
9 years ago
Nov 02, 2015
Bought 34.8 K USD
HIGDON LEO I JR
Director
+ 1000
34.81 USD
10 years ago
Feb 27, 2015
Sell 482 K USD
Tarr Mark J
EVP and COO
- 11000
43.8247 USD
10 years ago
Feb 27, 2015
Sell 50.2 K USD
Price Andrew L
Chief Accounting Officer
- 1145
43.844 USD
10 years ago
May 08, 2014
Sell 333 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 10000
33.286 USD
10 years ago
May 09, 2014
Sell 265 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 8000
33.167 USD
10 years ago
May 07, 2014
Sell 672 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 20000
33.589 USD
10 years ago
May 05, 2014
Sell 345 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 10000
34.483 USD
10 years ago
May 02, 2014
Sell 119 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 3400
35 USD
10 years ago
May 02, 2014
Sell 178 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 5000
35.574 USD
10 years ago
May 05, 2014
Sell 433 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 12600
34.392 USD
10 years ago
May 06, 2014
Sell 651 K USD
GRINNEY JAY
Pres & Chief Executive Officer
- 19000
34.242 USD
10 years ago
Mar 07, 2014
Sell 1.82 M USD
GRINNEY JAY
Pres & Chief Executive Officer
- 56000
32.5549 USD
11 years ago
Mar 06, 2014
Sell 1.08 M USD
GRINNEY JAY
Pres & Chief Executive Officer
- 33000
32.5926 USD
11 years ago
Nov 14, 2013
Sell 388 K USD
Tarr Mark J
EVP and COO
- 11000
35.2676 USD
11 years ago
May 06, 2013
Bought 28.4 K USD
KATZ LESLYE G
Director
+ 1000
28.396 USD
11 years ago
May 02, 2013
Sell 61.8 K USD
Levy Cheryl B.
Chief Human Resources Officer
- 2220
27.8353 USD
12 years ago
Nov 07, 2012
Bought 248 K USD
GRINNEY JAY
Chief Executive Officer
+ 11300
21.951 USD
12 years ago
Aug 02, 2012
Sell 108 K USD
HANSON JON F
Director
- 5000
21.69 USD
12 years ago
Aug 02, 2012
Sell 17.4 K USD
Tarr Mark J
EVP and COO
- 800
21.78 USD
12 years ago
Aug 01, 2012
Sell 161 K USD
Tarr Mark J
EVP and COO
- 7200
22.3062 USD
13 years ago
Mar 06, 2012
Bought 40 K USD
BLECHSCHMIDT EDWARD A
Director
+ 2000
20.01 USD
13 years ago
Mar 02, 2012
Bought 4 K USD
BLECHSCHMIDT EDWARD A
Director
+ 200
20.01 USD
13 years ago
Mar 01, 2012
Bought 20.4 K USD
BLECHSCHMIDT EDWARD A
Director
+ 1000
20.45 USD
13 years ago
Feb 28, 2012
Sell 526 K USD
Price Andrew L
Chief Accounting Officer
- 25000
21.03 USD
14 years ago
Nov 08, 2010
Bought 36.2 K USD
CORRELL DONALD L
Director
+ 2000
18.12 USD
15 years ago
Mar 18, 2009
Bought 75.3 K USD
Clohan Dexanne B
SVP & Chief Medical Officer
+ 9000
8.368 USD
16 years ago
Nov 26, 2008
Bought 10 K USD
MAUPIN JOHN E JR D D S
Director
+ 1000
10.0488 USD
16 years ago
Nov 21, 2008
Bought 8.99 K USD
BLECHSCHMIDT EDWARD A
Director
+ 1000
8.99 USD
16 years ago
Nov 21, 2008
Bought 9.15 K USD
BLECHSCHMIDT EDWARD A
Director
+ 1000
9.15 USD
16 years ago
Nov 20, 2008
Bought 9.52 K USD
BLECHSCHMIDT EDWARD A
Director
+ 1000
9.52 USD
16 years ago
Nov 20, 2008
Bought 9.79 K USD
BLECHSCHMIDT EDWARD A
Director
+ 1000
9.79 USD
16 years ago
Nov 12, 2008
Bought 43.2 K USD
Whittington John P
Gen. Counsel & Secretary
+ 4000
10.7988 USD
16 years ago
Nov 12, 2008
Bought 54.1 K USD
Whittington John P
Gen. Counsel & Secretary
+ 5000
10.82 USD
16 years ago
Nov 13, 2008
Bought 3.26 K USD
SHAW L EDWARD JR
Director
+ 300
10.88 USD
16 years ago
Nov 13, 2008
Bought 4.35 K USD
SHAW L EDWARD JR
Director
+ 400
10.87 USD
16 years ago
Nov 13, 2008
Bought 4.34 K USD
SHAW L EDWARD JR
Director
+ 400
10.86 USD
16 years ago
Nov 13, 2008
Bought 1.08 K USD
SHAW L EDWARD JR
Director
+ 100
10.85 USD
16 years ago
Nov 13, 2008
Bought 24.9 K USD
SHAW L EDWARD JR
Director
+ 2300
10.84 USD
16 years ago
Nov 13, 2008
Bought 14.1 K USD
SHAW L EDWARD JR
Director
+ 1300
10.83 USD
16 years ago
Nov 13, 2008
Bought 2.16 K USD
SHAW L EDWARD JR
Director
+ 200
10.82 USD
16 years ago
Nov 13, 2008
Bought 10.3 K USD
BLECHSCHMIDT EDWARD A
Director
+ 1000
10.3 USD
16 years ago
Nov 12, 2008
Bought 10.5 K USD
BLECHSCHMIDT EDWARD A
Director
+ 1000
10.51 USD
16 years ago
Nov 12, 2008
Bought 35.7 K USD
Fay Edmund
Sr. Vice Pres. and Treasurer
+ 3250
10.99 USD
16 years ago
Nov 10, 2008
Bought 16.5 K USD
Workman John L
Chief Financial Officer
+ 1400
11.757 USD
16 years ago
Nov 10, 2008
Bought 28.3 K USD
Workman John L
Chief Financial Officer
+ 2400
11.78 USD
16 years ago
Nov 10, 2008
Bought 3.52 K USD
Workman John L
Chief Financial Officer
+ 300
11.74 USD
16 years ago
Nov 10, 2008
Bought 9.41 K USD
Workman John L
Chief Financial Officer
+ 800
11.76 USD
16 years ago
Nov 10, 2008
Bought 1.18 K USD
Workman John L
Chief Financial Officer
+ 100
11.75 USD
16 years ago
Nov 10, 2008
Bought 6.23 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
12.46 USD
16 years ago
Nov 10, 2008
Bought 7.44 K USD
GRINNEY JAY
Chief Executive Officer
+ 600
12.4 USD
16 years ago
Nov 10, 2008
Bought 6.2 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
12.39 USD
16 years ago
Nov 10, 2008
Bought 12.4 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
12.38 USD
16 years ago
Nov 10, 2008
Bought 18.6 K USD
GRINNEY JAY
Chief Executive Officer
+ 1500
12.37 USD
16 years ago
Nov 10, 2008
Bought 6.18 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
12.35 USD
16 years ago
Nov 10, 2008
Bought 6.17 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
12.34 USD
16 years ago
Nov 10, 2008
Bought 12.3 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
12.3 USD
16 years ago
Nov 10, 2008
Bought 6.14 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
12.29 USD
16 years ago
Nov 10, 2008
Bought 38 K USD
GRINNEY JAY
Chief Executive Officer
+ 3100
12.25 USD
16 years ago
Nov 10, 2008
Bought 30.6 K USD
GRINNEY JAY
Chief Executive Officer
+ 2500
12.24 USD
16 years ago
Nov 10, 2008
Bought 58.7 K USD
GRINNEY JAY
Chief Executive Officer
+ 4800
12.23 USD
16 years ago
Nov 10, 2008
Bought 24.4 K USD
GRINNEY JAY
Chief Executive Officer
+ 2000
12.22 USD
16 years ago
Nov 10, 2008
Bought 14.7 K USD
GRINNEY JAY
Chief Executive Officer
+ 1200
12.21 USD
16 years ago
Nov 10, 2008
Bought 34.2 K USD
GRINNEY JAY
Chief Executive Officer
+ 2800
12.2 USD
16 years ago
Nov 10, 2008
Bought 23.2 K USD
GRINNEY JAY
Chief Executive Officer
+ 1900
12.19 USD
16 years ago
Nov 10, 2008
Bought 40.2 K USD
GRINNEY JAY
Chief Executive Officer
+ 3300
12.18 USD
16 years ago
Nov 10, 2008
Bought 53.5 K USD
GRINNEY JAY
Chief Executive Officer
+ 4400
12.17 USD
16 years ago
Nov 10, 2008
Bought 26.8 K USD
GRINNEY JAY
Chief Executive Officer
+ 2200
12.16 USD
16 years ago
Nov 10, 2008
Bought 60.8 K USD
GRINNEY JAY
Chief Executive Officer
+ 5000
12.15 USD
16 years ago
Nov 10, 2008
Bought 25.5 K USD
GRINNEY JAY
Chief Executive Officer
+ 2100
12.14 USD
16 years ago
Nov 10, 2008
Bought 48.5 K USD
GRINNEY JAY
Chief Executive Officer
+ 4000
12.13 USD
16 years ago
Nov 10, 2008
Bought 30.3 K USD
GRINNEY JAY
Chief Executive Officer
+ 2500
12.12 USD
16 years ago
Nov 10, 2008
Bought 27.9 K USD
GRINNEY JAY
Chief Executive Officer
+ 2300
12.11 USD
16 years ago
Nov 10, 2008
Bought 20.8 K USD
GRINNEY JAY
Chief Executive Officer
+ 1717
12.1 USD
16 years ago
Nov 10, 2008
Bought 39.9 K USD
GRINNEY JAY
Chief Executive Officer
+ 3300
12.09 USD
16 years ago
Nov 10, 2008
Bought 12 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
12.05 USD
16 years ago
Nov 10, 2008
Bought 12.1 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
12.07 USD
16 years ago
Nov 10, 2008
Bought 12 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
12.02 USD
16 years ago
Nov 10, 2008
Bought 18 K USD
GRINNEY JAY
Chief Executive Officer
+ 1500
12 USD
16 years ago
Nov 10, 2008
Bought 6 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
11.99 USD
16 years ago
Nov 10, 2008
Bought 5.99 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
11.98 USD
16 years ago
Nov 10, 2008
Bought 16.8 K USD
GRINNEY JAY
Chief Executive Officer
+ 1400
11.97 USD
16 years ago
Nov 10, 2008
Bought 12 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
11.96 USD
16 years ago
Nov 10, 2008
Bought 5.98 K USD
GRINNEY JAY
Chief Executive Officer
+ 500
11.95 USD
16 years ago
Nov 10, 2008
Bought 11.9 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
11.94 USD
16 years ago
Nov 10, 2008
Bought 11.9 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
11.93 USD
16 years ago
Nov 10, 2008
Bought 15.5 K USD
GRINNEY JAY
Chief Executive Officer
+ 1300
11.91 USD
16 years ago
Nov 10, 2008
Bought 7.14 K USD
GRINNEY JAY
Chief Executive Officer
+ 600
11.9 USD
16 years ago
Nov 10, 2008
Bought 3.57 K USD
GRINNEY JAY
Chief Executive Officer
+ 300
11.89 USD
16 years ago
Nov 10, 2008
Bought 1.19 K USD
GRINNEY JAY
Chief Executive Officer
+ 100
11.86 USD
16 years ago
Nov 10, 2008
Bought 1.97 K USD
GRINNEY JAY
Chief Executive Officer
+ 166
11.85 USD
16 years ago
Nov 10, 2008
Bought 12.9 K USD
GRINNEY JAY
Chief Executive Officer
+ 1100
11.77 USD
16 years ago
Nov 10, 2008
Bought 1.18 K USD
GRINNEY JAY
Chief Executive Officer
+ 100
11.76 USD
16 years ago
Nov 10, 2008
Bought 18.8 K USD
GRINNEY JAY
Chief Executive Officer
+ 1600
11.72 USD
16 years ago
Nov 10, 2008
Bought 11.7 K USD
GRINNEY JAY
Chief Executive Officer
+ 1000
11.71 USD
17 years ago
Mar 05, 2008
Bought 99.4 K USD
Whittington John P
EVP, Gen. Counsel & Secretary
+ 6250
15.903 USD
17 years ago
Nov 23, 2007
Bought 39.4 K USD
SHAW L EDWARD JR
Director
+ 2000
19.6755 USD
17 years ago
Nov 16, 2007
Bought 699 USD
Workman John L
Chief Financial Officer
+ 35
19.9799 USD
17 years ago
Nov 16, 2007
Bought 12 K USD
Workman John L
Chief Financial Officer
+ 600
19.98 USD
17 years ago
Nov 16, 2007
Bought 37.3 K USD
Workman John L
Chief Financial Officer
+ 1865
20 USD
17 years ago
Aug 16, 2007
Bought 181 K USD
HANSON JON F
Director
+ 10000
18.06 USD
17 years ago
Aug 16, 2007
Bought 99.6 K USD
ELSON CHARLES M
Director
+ 5650
17.6344 USD
17 years ago
Aug 16, 2007
Bought 1.77 K USD
Workman John L
Chief Financial Officer
+ 100
17.74 USD
17 years ago
Aug 16, 2007
Bought 1.77 K USD
Workman John L
Chief Financial Officer
+ 100
17.73 USD
17 years ago
Aug 16, 2007
Bought 1.77 K USD
Workman John L
Chief Financial Officer
+ 100
17.71 USD
17 years ago
Aug 16, 2007
Bought 30.2 K USD
Workman John L
Chief Financial Officer
+ 1700
17.75 USD
17 years ago
Aug 15, 2007
Bought 985 K USD
GRINNEY JAY
Chief Executive Officer
+ 56263
17.5105 USD
17 years ago
Aug 14, 2007
Bought 25.9 K USD
GRINNEY JAY
Chief Executive Officer
+ 1480
17.5 USD
17 years ago
Aug 14, 2007
Bought 989 K USD
GRINNEY JAY
Chief Executive Officer
+ 57000
17.3494 USD
17 years ago
Aug 14, 2007
Bought 278 USD
Workman John L
Chief Financial Officer
+ 16
17.37 USD
17 years ago
Aug 14, 2007
Bought 1.74 K USD
Workman John L
Chief Financial Officer
+ 100
17.36 USD
17 years ago
Aug 14, 2007
Bought 3.48 K USD
Workman John L
Chief Financial Officer
+ 200
17.38 USD
17 years ago
Aug 14, 2007
Bought 1.73 K USD
Workman John L
Chief Financial Officer
+ 100
17.33 USD
17 years ago
Aug 14, 2007
Bought 65.7 K USD
Workman John L
Chief Financial Officer
+ 3800
17.28 USD
17 years ago
Aug 14, 2007
Bought 13.9 K USD
Workman John L
Chief Financial Officer
+ 800
17.39 USD
17 years ago
Aug 14, 2007
Bought 1.74 K USD
Workman John L
Chief Financial Officer
+ 100
17.41 USD
17 years ago
Aug 14, 2007
Bought 45 K USD
Workman John L
Chief Financial Officer
+ 2584
17.4 USD
17 years ago
Aug 14, 2007
Bought 91.7 K USD
Workman John L
Chief Financial Officer
+ 5300
17.3 USD
17 years ago
Aug 14, 2007
Bought 34.8 K USD
Tarr Mark J
Executive Vice President
+ 2000
17.38 USD
17 years ago
Aug 14, 2007
Bought 52.2 K USD
Tarr Mark J
Executive Vice President
+ 3000
17.4 USD
17 years ago
Aug 14, 2007
Bought 61.9 K USD
Tarr Mark J
Executive Vice President
+ 3600
17.2 USD
17 years ago
Aug 14, 2007
Bought 102 K USD
Whittington John P
Gen. Counsel & Secretary
+ 5800
17.531 USD
21 years ago
Jan 29, 2004
Bought 100 K USD
STRONG GEORGE H
Director
+ 20000
5 USD
7. News
Encompass Health Declares Dividend on Common Stock BIRMINGHAM, Ala. , Feb. 20, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on April 15, 2025, to holders of record on April 1, 2025. prnewswire.com - 1 week ago
Encompass Health Q4 Earnings Beat on Strong Discharge Growth EHC expects adjusted EPS from continuing operations in the range of $4.67-$4.96 in 2025. zacks.com - 2 weeks ago
Encompass Health Corporation (EHC) Q4 2024 Earnings Call Transcript Encompass Health Corporation (NYSE:EHC ) Q4 2024 Earnings Conference Call February 7, 2024 10:00 AM ET Corporate Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President and Chief Executive Officer Douglas Coltharp - Executive Vice President and Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners Matthew Gilmore - KeyBanc A.J. Rice - UBS Andrew Mok - Barclays Joanna Gajic - Bank of America Ann Hynes - Mizuho Scott Fidel - Stephens Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Brian Tanquilut - Jefferies Jared Haase - William Blair Operator Good morning, everyone, and welcome to Encompass Health's Fourth Quarter 2024 Earnings Conference Call. seekingalpha.com - 3 weeks ago
Encompass Health (EHC) Reports Q4 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Encompass Health (EHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 3 weeks ago
Encompass Health (EHC) Beats Q4 Earnings and Revenue Estimates Encompass Health (EHC) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.95 per share a year ago. zacks.com - 3 weeks ago
Encompass Health reports results for fourth quarter 2024 and issues 2025 guidance BIRMINGHAM, Ala. , Feb. 6, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the fourth quarter ended December 31, 2024. prnewswire.com - 3 weeks ago
Encompass Health Named One of Fortune's World's Most Admired Companies for Fifth Consecutive Year BIRMINGHAM, Ala. , Feb. 5, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, today announced it has been named to Fortune's World's Most Admired Companies list for 2025. prnewswire.com - 3 weeks ago
Stay Ahead of the Game With Encompass Health (EHC) Q4 Earnings: Wall Street's Insights on Key Metrics Evaluate the expected performance of Encompass Health (EHC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com - 3 weeks ago
Here's Why Encompass Health (EHC) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 1 month ago
Encompass Health Announces Date of 2024 Fourth Quarter Earnings Call BIRMINGHAM, Ala. , Jan. 8, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2024, after the market closes on Thursday, Feb. 6, 2025. prnewswire.com - 1 month ago
Encompass Health Named Among Most Trusted Companies in America by Forbes BIRMINGHAM, Ala. , Jan. 7, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, has been recognized by Forbes on their inaugural list of the Most Trusted Companies in America. prnewswire.com - 1 month ago
Here's Why Encompass Health is a Smart Addition to Your Portfolio EHC is well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, frequent expansion initiatives and solid cash reserves. zacks.com - 2 months ago
8. Profile Summary

Encompass Health Corporation EHC

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 10.1 B
Dividend Yield 0.00%
Description Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Contact 9001 Liberty Parkway, Birmingham, AL, 35242 https://www.encompasshealth.com
IPO Date Sept. 24, 1986
Employees 28188
Officers Dr. Elissa Joy Charbonneau D.O., M.S. Chief Medical Officer Mr. Mark Miller Senior Vice President of Investor Relations & Strategic Planning Ms. Dawn Rock Chief Compliance Officer Mr. Douglas E. Coltharp Executive Vice President & Chief Financial Officer Mr. Mark J. Tarr Chief Executive Officer, President & Director Mr. Rusty Yeager Chief Information Officer & Senior Vice President Mr. Anthony A. Hernandez Chief Human Resources Officer Mr. John Patrick Darby Executive Vice President, General Counsel & Corporate Secretary Mr. Andrew L. Price Senior Vice President & Chief Accounting Officer Mr. Frank Brown President of Southwest Region